SNWV
SANUWAVE Health Inc. (SNWV) SWOT Analysis Analysis (2026)
No material changes this month.
Strengths
Low net debt to EBITDA of 0.59 supports balance-sheet flexibility versus more levered peers, partially offsetting weak operating profitability.
Current ratio of 1.28 indicates adequate short-term liquidity, which is better than distressed peers but not strong enough to imply durable funding advantage.
Quick ratio of 0.89 suggests near-term obligations are mostly covered by liquid assets, leaving the company less exposed than weaker peers in tight credit conditions.
Weaknesses
Debt to equity of 7.43 is materially elevated versus peers, indicating a highly leveraged capital structure that constrains strategic flexibility and earnings resilience.
ROIC of 2.8% is well below typical cost-of-capital thresholds, showing the business converts invested capital into returns less effectively than stronger peers.
Cash conversion cycle of 174.3 days is very long versus peers, tying up working capital and pressuring liquidity, margins, and reinvestment capacity.
Opportunities
Improving working-capital discipline could shorten the 174.3-day cash conversion cycle, releasing cash faster than peers with less efficient operating cycles.
If leverage is reduced further from the current 0.59 net debt to EBITDA, the company could narrow its financing-cost gap versus stronger balance-sheet peers.
Any sustained lift in ROIC from the current 2.8% would materially improve competitive positioning because peers with higher capital efficiency can compound value faster.
Threats
High leverage leaves the company more vulnerable than peers to refinancing pressure if rates stay elevated or credit conditions tighten.
Persistently weak ROIC versus peers increases the risk that capital is deployed into low-return assets, limiting long-term competitiveness and valuation support.
A prolonged 174.3-day cash conversion cycle can amplify working-capital strain versus peers, especially if customer payments slow or inventory builds.
Overall Score
SNWV’s structural positioning is weak versus peers because high leverage, poor capital efficiency, and an extended cash conversion cycle outweigh its modest liquidity and low net debt.
Sources
- Company filings (10-K, 10-Q, investor presentations)
- Financial and market data providers
- Public news and industry information
🔒 Go Beyond This Framework
This is one of 10 institutional-grade frameworks Invetso runs on SANUWAVE Health Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.
